investors can Contact the law firm for free to learn more about recovering their losses

LOS ANGELES, Nov. 3, 2022 (GLOBE NEWSWIRE) — The law firm of Portnoy informs investors of Instil Bio, Inc. (“Instill Bio”) (NASDAQ: TIL) that the law firm has opened an investigation on behalf of investors who have lost money on their shares of Instill Bio. Instill Bio investors are encouraged to do so Contact the company to discuss their legal rights.

Investors are encouraged to contact an attorney Lesley F Portnoyby phone 844-767-8529 or E-mail: [email protected] to discuss your legal rights, or click here to join the case about www.portnoylaw.com. Portnoy Law Firm can provide a free case assessment and discuss investors’ options for making claims to recover their losses.

The investigation focuses on whether the company misled investors regarding a clinical trial of ITIL-168. Instil Bio announced on October 31, 2022 that it had notified the FDA that it had voluntarily suspended enrollment in a clinical trial due to manufacturing issues with one of its therapies. Manufacturing issues meant that patients in a clinical trial of ITIL-168 for advanced melanoma could not be properly dosed. Based on this news, shares of Instil Bio fell more than 33% in intraday trading.

Please visit our website to verify further information and to submit your transaction information.

Portnoy Law Firm represents investors in asserting claims against companies caused by wrongdoing. The firm’s founding partner has recovered over $5.5 billion for aggrieved investors. attorney advertising. Previous results do not guarantee similar results.

Lesley F. Portnoy, Esq.
Bar Association in CA and NY
[email protected]
310-692-8883
www.portnoylaw.com

lawyer advertising